Global Respiratory Biologics Market Growth 2026-2032
The global Respiratory Biologics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Respiratory Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Respiratory Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Respiratory Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Respiratory Biologics players cover GSK, AstraZeneca, Sanofi, Genentech USA, Teva Respiratory, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Respiratory Biologics Industry Forecast? looks at past sales and reviews total world Respiratory Biologics sales in 2025, providing a comprehensive analysis by region and market sector of projected Respiratory Biologics sales for 2026 through 2032. With Respiratory Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Biologics industry.
This Insight Report provides a comprehensive analysis of the global Respiratory Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Respiratory Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Biologics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Biologics.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Respiratory Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Respiratory Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Respiratory Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Respiratory Biologics players cover GSK, AstraZeneca, Sanofi, Genentech USA, Teva Respiratory, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Respiratory Biologics Industry Forecast? looks at past sales and reviews total world Respiratory Biologics sales in 2025, providing a comprehensive analysis by region and market sector of projected Respiratory Biologics sales for 2026 through 2032. With Respiratory Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Biologics industry.
This Insight Report provides a comprehensive analysis of the global Respiratory Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Respiratory Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Biologics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Biologics.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Intravenous
- Subcuteneous
- Asthma
- Chronic Rhinosinasitis
- Hypereosinophilic Syndrome
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- AstraZeneca
- Sanofi
- Genentech USA
- Teva Respiratory
- Novartis
- Roche
- Boehringer Ingelheim
- Regeneron Pharmaceuticals
- Merck
- Johnson & Johnson
- Amgen
- Biogen
- Vertex Pharmaceuticals
- AbbVie
- What is the 10-year outlook for the global Respiratory Biologics market?
- What factors are driving Respiratory Biologics market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Respiratory Biologics market opportunities vary by end market size?
- How does Respiratory Biologics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Respiratory Biologics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Respiratory Biologics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Respiratory Biologics by Country/Region, 2021, 2025 & 2032
2.2 Respiratory Biologics Segment by Type
2.2.1 Intravenous
2.2.2 Subcuteneous
2.2.3 Respiratory Biologics Sales by Type
2.2.3.1 Global Respiratory Biologics Sales Market Share by Type (2021-2026)
2.2.3.2 Global Respiratory Biologics Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Respiratory Biologics Sale Price by Type (2021-2026)
2.3 Respiratory Biologics Segment by Application
2.3.1 Asthma
2.3.2 Chronic Rhinosinasitis
2.3.3 Hypereosinophilic Syndrome
2.3.4 Other
2.3.5 Respiratory Biologics Sales by Application
2.3.5.1 Global Respiratory Biologics Sale Market Share by Application (2021-2026)
2.3.5.2 Global Respiratory Biologics Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Respiratory Biologics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Respiratory Biologics Breakdown Data by Company
3.1.1 Global Respiratory Biologics Annual Sales by Company (2021-2026)
3.1.2 Global Respiratory Biologics Sales Market Share by Company (2021-2026)
3.2 Global Respiratory Biologics Annual Revenue by Company (2021-2026)
3.2.1 Global Respiratory Biologics Revenue by Company (2021-2026)
3.2.2 Global Respiratory Biologics Revenue Market Share by Company (2021-2026)
3.3 Global Respiratory Biologics Sale Price by Company
3.4 Key Manufacturers Respiratory Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Respiratory Biologics Product Location Distribution
3.4.2 Players Respiratory Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RESPIRATORY BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Respiratory Biologics Market Size by Geographic Region (2021-2026)
4.1.1 Global Respiratory Biologics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Respiratory Biologics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Respiratory Biologics Market Size by Country/Region (2021-2026)
4.2.1 Global Respiratory Biologics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Respiratory Biologics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Respiratory Biologics Sales Growth
4.4 APAC Respiratory Biologics Sales Growth
4.5 Europe Respiratory Biologics Sales Growth
4.6 Middle East & Africa Respiratory Biologics Sales Growth
5 AMERICAS
5.1 Americas Respiratory Biologics Sales by Country
5.1.1 Americas Respiratory Biologics Sales by Country (2021-2026)
5.1.2 Americas Respiratory Biologics Revenue by Country (2021-2026)
5.2 Americas Respiratory Biologics Sales by Type (2021-2026)
5.3 Americas Respiratory Biologics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Biologics Sales by Region
6.1.1 APAC Respiratory Biologics Sales by Region (2021-2026)
6.1.2 APAC Respiratory Biologics Revenue by Region (2021-2026)
6.2 APAC Respiratory Biologics Sales by Type (2021-2026)
6.3 APAC Respiratory Biologics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Respiratory Biologics by Country
7.1.1 Europe Respiratory Biologics Sales by Country (2021-2026)
7.1.2 Europe Respiratory Biologics Revenue by Country (2021-2026)
7.2 Europe Respiratory Biologics Sales by Type (2021-2026)
7.3 Europe Respiratory Biologics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Respiratory Biologics by Country
8.1.1 Middle East & Africa Respiratory Biologics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Respiratory Biologics Revenue by Country (2021-2026)
8.2 Middle East & Africa Respiratory Biologics Sales by Type (2021-2026)
8.3 Middle East & Africa Respiratory Biologics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Respiratory Biologics
10.3 Manufacturing Process Analysis of Respiratory Biologics
10.4 Industry Chain Structure of Respiratory Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Respiratory Biologics Distributors
11.3 Respiratory Biologics Customer
12 WORLD FORECAST REVIEW FOR RESPIRATORY BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Respiratory Biologics Market Size Forecast by Region
12.1.1 Global Respiratory Biologics Forecast by Region (2027-2032)
12.1.2 Global Respiratory Biologics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Respiratory Biologics Forecast by Type (2027-2032)
12.7 Global Respiratory Biologics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Respiratory Biologics Product Portfolios and Specifications
13.1.3 GSK Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Respiratory Biologics Product Portfolios and Specifications
13.2.3 AstraZeneca Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Respiratory Biologics Product Portfolios and Specifications
13.3.3 Sanofi Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Genentech USA
13.4.1 Genentech USA Company Information
13.4.2 Genentech USA Respiratory Biologics Product Portfolios and Specifications
13.4.3 Genentech USA Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Genentech USA Main Business Overview
13.4.5 Genentech USA Latest Developments
13.5 Teva Respiratory
13.5.1 Teva Respiratory Company Information
13.5.2 Teva Respiratory Respiratory Biologics Product Portfolios and Specifications
13.5.3 Teva Respiratory Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teva Respiratory Main Business Overview
13.5.5 Teva Respiratory Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Respiratory Biologics Product Portfolios and Specifications
13.6.3 Novartis Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Respiratory Biologics Product Portfolios and Specifications
13.7.3 Roche Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim Respiratory Biologics Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 Regeneron Pharmaceuticals
13.9.1 Regeneron Pharmaceuticals Company Information
13.9.2 Regeneron Pharmaceuticals Respiratory Biologics Product Portfolios and Specifications
13.9.3 Regeneron Pharmaceuticals Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Regeneron Pharmaceuticals Main Business Overview
13.9.5 Regeneron Pharmaceuticals Latest Developments
13.10 Merck
13.10.1 Merck Company Information
13.10.2 Merck Respiratory Biologics Product Portfolios and Specifications
13.10.3 Merck Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Merck Main Business Overview
13.10.5 Merck Latest Developments
13.11 Johnson & Johnson
13.11.1 Johnson & Johnson Company Information
13.11.2 Johnson & Johnson Respiratory Biologics Product Portfolios and Specifications
13.11.3 Johnson & Johnson Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Johnson & Johnson Main Business Overview
13.11.5 Johnson & Johnson Latest Developments
13.12 Amgen
13.12.1 Amgen Company Information
13.12.2 Amgen Respiratory Biologics Product Portfolios and Specifications
13.12.3 Amgen Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Amgen Main Business Overview
13.12.5 Amgen Latest Developments
13.13 Biogen
13.13.1 Biogen Company Information
13.13.2 Biogen Respiratory Biologics Product Portfolios and Specifications
13.13.3 Biogen Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Biogen Main Business Overview
13.13.5 Biogen Latest Developments
13.14 Vertex Pharmaceuticals
13.14.1 Vertex Pharmaceuticals Company Information
13.14.2 Vertex Pharmaceuticals Respiratory Biologics Product Portfolios and Specifications
13.14.3 Vertex Pharmaceuticals Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Vertex Pharmaceuticals Main Business Overview
13.14.5 Vertex Pharmaceuticals Latest Developments
13.15 AbbVie
13.15.1 AbbVie Company Information
13.15.2 AbbVie Respiratory Biologics Product Portfolios and Specifications
13.15.3 AbbVie Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 AbbVie Main Business Overview
13.15.5 AbbVie Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Respiratory Biologics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Respiratory Biologics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Respiratory Biologics by Country/Region, 2021, 2025 & 2032
2.2 Respiratory Biologics Segment by Type
2.2.1 Intravenous
2.2.2 Subcuteneous
2.2.3 Respiratory Biologics Sales by Type
2.2.3.1 Global Respiratory Biologics Sales Market Share by Type (2021-2026)
2.2.3.2 Global Respiratory Biologics Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Respiratory Biologics Sale Price by Type (2021-2026)
2.3 Respiratory Biologics Segment by Application
2.3.1 Asthma
2.3.2 Chronic Rhinosinasitis
2.3.3 Hypereosinophilic Syndrome
2.3.4 Other
2.3.5 Respiratory Biologics Sales by Application
2.3.5.1 Global Respiratory Biologics Sale Market Share by Application (2021-2026)
2.3.5.2 Global Respiratory Biologics Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Respiratory Biologics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Respiratory Biologics Breakdown Data by Company
3.1.1 Global Respiratory Biologics Annual Sales by Company (2021-2026)
3.1.2 Global Respiratory Biologics Sales Market Share by Company (2021-2026)
3.2 Global Respiratory Biologics Annual Revenue by Company (2021-2026)
3.2.1 Global Respiratory Biologics Revenue by Company (2021-2026)
3.2.2 Global Respiratory Biologics Revenue Market Share by Company (2021-2026)
3.3 Global Respiratory Biologics Sale Price by Company
3.4 Key Manufacturers Respiratory Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Respiratory Biologics Product Location Distribution
3.4.2 Players Respiratory Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RESPIRATORY BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Respiratory Biologics Market Size by Geographic Region (2021-2026)
4.1.1 Global Respiratory Biologics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Respiratory Biologics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Respiratory Biologics Market Size by Country/Region (2021-2026)
4.2.1 Global Respiratory Biologics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Respiratory Biologics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Respiratory Biologics Sales Growth
4.4 APAC Respiratory Biologics Sales Growth
4.5 Europe Respiratory Biologics Sales Growth
4.6 Middle East & Africa Respiratory Biologics Sales Growth
5 AMERICAS
5.1 Americas Respiratory Biologics Sales by Country
5.1.1 Americas Respiratory Biologics Sales by Country (2021-2026)
5.1.2 Americas Respiratory Biologics Revenue by Country (2021-2026)
5.2 Americas Respiratory Biologics Sales by Type (2021-2026)
5.3 Americas Respiratory Biologics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Biologics Sales by Region
6.1.1 APAC Respiratory Biologics Sales by Region (2021-2026)
6.1.2 APAC Respiratory Biologics Revenue by Region (2021-2026)
6.2 APAC Respiratory Biologics Sales by Type (2021-2026)
6.3 APAC Respiratory Biologics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Respiratory Biologics by Country
7.1.1 Europe Respiratory Biologics Sales by Country (2021-2026)
7.1.2 Europe Respiratory Biologics Revenue by Country (2021-2026)
7.2 Europe Respiratory Biologics Sales by Type (2021-2026)
7.3 Europe Respiratory Biologics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Respiratory Biologics by Country
8.1.1 Middle East & Africa Respiratory Biologics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Respiratory Biologics Revenue by Country (2021-2026)
8.2 Middle East & Africa Respiratory Biologics Sales by Type (2021-2026)
8.3 Middle East & Africa Respiratory Biologics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Respiratory Biologics
10.3 Manufacturing Process Analysis of Respiratory Biologics
10.4 Industry Chain Structure of Respiratory Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Respiratory Biologics Distributors
11.3 Respiratory Biologics Customer
12 WORLD FORECAST REVIEW FOR RESPIRATORY BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Respiratory Biologics Market Size Forecast by Region
12.1.1 Global Respiratory Biologics Forecast by Region (2027-2032)
12.1.2 Global Respiratory Biologics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Respiratory Biologics Forecast by Type (2027-2032)
12.7 Global Respiratory Biologics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Respiratory Biologics Product Portfolios and Specifications
13.1.3 GSK Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Respiratory Biologics Product Portfolios and Specifications
13.2.3 AstraZeneca Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Respiratory Biologics Product Portfolios and Specifications
13.3.3 Sanofi Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Genentech USA
13.4.1 Genentech USA Company Information
13.4.2 Genentech USA Respiratory Biologics Product Portfolios and Specifications
13.4.3 Genentech USA Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Genentech USA Main Business Overview
13.4.5 Genentech USA Latest Developments
13.5 Teva Respiratory
13.5.1 Teva Respiratory Company Information
13.5.2 Teva Respiratory Respiratory Biologics Product Portfolios and Specifications
13.5.3 Teva Respiratory Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teva Respiratory Main Business Overview
13.5.5 Teva Respiratory Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Respiratory Biologics Product Portfolios and Specifications
13.6.3 Novartis Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Respiratory Biologics Product Portfolios and Specifications
13.7.3 Roche Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim Respiratory Biologics Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 Regeneron Pharmaceuticals
13.9.1 Regeneron Pharmaceuticals Company Information
13.9.2 Regeneron Pharmaceuticals Respiratory Biologics Product Portfolios and Specifications
13.9.3 Regeneron Pharmaceuticals Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Regeneron Pharmaceuticals Main Business Overview
13.9.5 Regeneron Pharmaceuticals Latest Developments
13.10 Merck
13.10.1 Merck Company Information
13.10.2 Merck Respiratory Biologics Product Portfolios and Specifications
13.10.3 Merck Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Merck Main Business Overview
13.10.5 Merck Latest Developments
13.11 Johnson & Johnson
13.11.1 Johnson & Johnson Company Information
13.11.2 Johnson & Johnson Respiratory Biologics Product Portfolios and Specifications
13.11.3 Johnson & Johnson Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Johnson & Johnson Main Business Overview
13.11.5 Johnson & Johnson Latest Developments
13.12 Amgen
13.12.1 Amgen Company Information
13.12.2 Amgen Respiratory Biologics Product Portfolios and Specifications
13.12.3 Amgen Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Amgen Main Business Overview
13.12.5 Amgen Latest Developments
13.13 Biogen
13.13.1 Biogen Company Information
13.13.2 Biogen Respiratory Biologics Product Portfolios and Specifications
13.13.3 Biogen Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Biogen Main Business Overview
13.13.5 Biogen Latest Developments
13.14 Vertex Pharmaceuticals
13.14.1 Vertex Pharmaceuticals Company Information
13.14.2 Vertex Pharmaceuticals Respiratory Biologics Product Portfolios and Specifications
13.14.3 Vertex Pharmaceuticals Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Vertex Pharmaceuticals Main Business Overview
13.14.5 Vertex Pharmaceuticals Latest Developments
13.15 AbbVie
13.15.1 AbbVie Company Information
13.15.2 AbbVie Respiratory Biologics Product Portfolios and Specifications
13.15.3 AbbVie Respiratory Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 AbbVie Main Business Overview
13.15.5 AbbVie Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Respiratory Biologics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Respiratory Biologics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intravenous
Table 4. Major Players of Subcuteneous
Table 5. Global Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 6. Global Respiratory Biologics Sales Market Share by Type (2021-2026)
Table 7. Global Respiratory Biologics Revenue by Type (2021-2026) & ($ million)
Table 8. Global Respiratory Biologics Revenue Market Share by Type (2021-2026)
Table 9. Global Respiratory Biologics Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Respiratory Biologics Sale by Application (2021-2026) & (K Units)
Table 11. Global Respiratory Biologics Sale Market Share by Application (2021-2026)
Table 12. Global Respiratory Biologics Revenue by Application (2021-2026) & ($ million)
Table 13. Global Respiratory Biologics Revenue Market Share by Application (2021-2026)
Table 14. Global Respiratory Biologics Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Respiratory Biologics Sales by Company (2021-2026) & (K Units)
Table 16. Global Respiratory Biologics Sales Market Share by Company (2021-2026)
Table 17. Global Respiratory Biologics Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Respiratory Biologics Revenue Market Share by Company (2021-2026)
Table 19. Global Respiratory Biologics Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Respiratory Biologics Producing Area Distribution and Sales Area
Table 21. Players Respiratory Biologics Products Offered
Table 22. Respiratory Biologics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Respiratory Biologics Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Respiratory Biologics Sales Market Share Geographic Region (2021-2026)
Table 27. Global Respiratory Biologics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Respiratory Biologics Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Respiratory Biologics Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Respiratory Biologics Sales Market Share by Country/Region (2021-2026)
Table 31. Global Respiratory Biologics Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Respiratory Biologics Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Respiratory Biologics Sales by Country (2021-2026) & (K Units)
Table 34. Americas Respiratory Biologics Sales Market Share by Country (2021-2026)
Table 35. Americas Respiratory Biologics Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 37. Americas Respiratory Biologics Sales by Application (2021-2026) & (K Units)
Table 38. APAC Respiratory Biologics Sales by Region (2021-2026) & (K Units)
Table 39. APAC Respiratory Biologics Sales Market Share by Region (2021-2026)
Table 40. APAC Respiratory Biologics Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 42. APAC Respiratory Biologics Sales by Application (2021-2026) & (K Units)
Table 43. Europe Respiratory Biologics Sales by Country (2021-2026) & (K Units)
Table 44. Europe Respiratory Biologics Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 46. Europe Respiratory Biologics Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Respiratory Biologics Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Respiratory Biologics Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Respiratory Biologics Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Respiratory Biologics
Table 52. Key Market Challenges & Risks of Respiratory Biologics
Table 53. Key Industry Trends of Respiratory Biologics
Table 54. Respiratory Biologics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Respiratory Biologics Distributors List
Table 57. Respiratory Biologics Customer List
Table 58. Global Respiratory Biologics Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Respiratory Biologics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Respiratory Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Respiratory Biologics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Respiratory Biologics Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Respiratory Biologics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Respiratory Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Respiratory Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Respiratory Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Respiratory Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Respiratory Biologics Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Respiratory Biologics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Respiratory Biologics Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Respiratory Biologics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. GSK Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Respiratory Biologics Product Portfolios and Specifications
Table 74. GSK Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. AstraZeneca Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca Respiratory Biologics Product Portfolios and Specifications
Table 79. AstraZeneca Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Sanofi Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Respiratory Biologics Product Portfolios and Specifications
Table 84. Sanofi Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Genentech USA Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 88. Genentech USA Respiratory Biologics Product Portfolios and Specifications
Table 89. Genentech USA Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Genentech USA Main Business
Table 91. Genentech USA Latest Developments
Table 92. Teva Respiratory Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Respiratory Respiratory Biologics Product Portfolios and Specifications
Table 94. Teva Respiratory Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Teva Respiratory Main Business
Table 96. Teva Respiratory Latest Developments
Table 97. Novartis Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Respiratory Biologics Product Portfolios and Specifications
Table 99. Novartis Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Roche Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 103. Roche Respiratory Biologics Product Portfolios and Specifications
Table 104. Roche Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Roche Main Business
Table 106. Roche Latest Developments
Table 107. Boehringer Ingelheim Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim Respiratory Biologics Product Portfolios and Specifications
Table 109. Boehringer Ingelheim Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Boehringer Ingelheim Main Business
Table 111. Boehringer Ingelheim Latest Developments
Table 112. Regeneron Pharmaceuticals Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 113. Regeneron Pharmaceuticals Respiratory Biologics Product Portfolios and Specifications
Table 114. Regeneron Pharmaceuticals Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Regeneron Pharmaceuticals Main Business
Table 116. Regeneron Pharmaceuticals Latest Developments
Table 117. Merck Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck Respiratory Biologics Product Portfolios and Specifications
Table 119. Merck Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Merck Main Business
Table 121. Merck Latest Developments
Table 122. Johnson & Johnson Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 123. Johnson & Johnson Respiratory Biologics Product Portfolios and Specifications
Table 124. Johnson & Johnson Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Johnson & Johnson Main Business
Table 126. Johnson & Johnson Latest Developments
Table 127. Amgen Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 128. Amgen Respiratory Biologics Product Portfolios and Specifications
Table 129. Amgen Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Amgen Main Business
Table 131. Amgen Latest Developments
Table 132. Biogen Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 133. Biogen Respiratory Biologics Product Portfolios and Specifications
Table 134. Biogen Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Biogen Main Business
Table 136. Biogen Latest Developments
Table 137. Vertex Pharmaceuticals Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 138. Vertex Pharmaceuticals Respiratory Biologics Product Portfolios and Specifications
Table 139. Vertex Pharmaceuticals Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Vertex Pharmaceuticals Main Business
Table 141. Vertex Pharmaceuticals Latest Developments
Table 142. AbbVie Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 143. AbbVie Respiratory Biologics Product Portfolios and Specifications
Table 144. AbbVie Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. AbbVie Main Business
Table 146. AbbVie Latest Developments
Table 1. Respiratory Biologics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Respiratory Biologics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intravenous
Table 4. Major Players of Subcuteneous
Table 5. Global Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 6. Global Respiratory Biologics Sales Market Share by Type (2021-2026)
Table 7. Global Respiratory Biologics Revenue by Type (2021-2026) & ($ million)
Table 8. Global Respiratory Biologics Revenue Market Share by Type (2021-2026)
Table 9. Global Respiratory Biologics Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Respiratory Biologics Sale by Application (2021-2026) & (K Units)
Table 11. Global Respiratory Biologics Sale Market Share by Application (2021-2026)
Table 12. Global Respiratory Biologics Revenue by Application (2021-2026) & ($ million)
Table 13. Global Respiratory Biologics Revenue Market Share by Application (2021-2026)
Table 14. Global Respiratory Biologics Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Respiratory Biologics Sales by Company (2021-2026) & (K Units)
Table 16. Global Respiratory Biologics Sales Market Share by Company (2021-2026)
Table 17. Global Respiratory Biologics Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Respiratory Biologics Revenue Market Share by Company (2021-2026)
Table 19. Global Respiratory Biologics Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Respiratory Biologics Producing Area Distribution and Sales Area
Table 21. Players Respiratory Biologics Products Offered
Table 22. Respiratory Biologics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Respiratory Biologics Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Respiratory Biologics Sales Market Share Geographic Region (2021-2026)
Table 27. Global Respiratory Biologics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Respiratory Biologics Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Respiratory Biologics Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Respiratory Biologics Sales Market Share by Country/Region (2021-2026)
Table 31. Global Respiratory Biologics Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Respiratory Biologics Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Respiratory Biologics Sales by Country (2021-2026) & (K Units)
Table 34. Americas Respiratory Biologics Sales Market Share by Country (2021-2026)
Table 35. Americas Respiratory Biologics Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 37. Americas Respiratory Biologics Sales by Application (2021-2026) & (K Units)
Table 38. APAC Respiratory Biologics Sales by Region (2021-2026) & (K Units)
Table 39. APAC Respiratory Biologics Sales Market Share by Region (2021-2026)
Table 40. APAC Respiratory Biologics Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 42. APAC Respiratory Biologics Sales by Application (2021-2026) & (K Units)
Table 43. Europe Respiratory Biologics Sales by Country (2021-2026) & (K Units)
Table 44. Europe Respiratory Biologics Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 46. Europe Respiratory Biologics Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Respiratory Biologics Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Respiratory Biologics Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Respiratory Biologics Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Respiratory Biologics Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Respiratory Biologics
Table 52. Key Market Challenges & Risks of Respiratory Biologics
Table 53. Key Industry Trends of Respiratory Biologics
Table 54. Respiratory Biologics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Respiratory Biologics Distributors List
Table 57. Respiratory Biologics Customer List
Table 58. Global Respiratory Biologics Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Respiratory Biologics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Respiratory Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Respiratory Biologics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Respiratory Biologics Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Respiratory Biologics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Respiratory Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Respiratory Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Respiratory Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Respiratory Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Respiratory Biologics Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Respiratory Biologics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Respiratory Biologics Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Respiratory Biologics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. GSK Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Respiratory Biologics Product Portfolios and Specifications
Table 74. GSK Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. AstraZeneca Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca Respiratory Biologics Product Portfolios and Specifications
Table 79. AstraZeneca Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Sanofi Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Respiratory Biologics Product Portfolios and Specifications
Table 84. Sanofi Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Genentech USA Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 88. Genentech USA Respiratory Biologics Product Portfolios and Specifications
Table 89. Genentech USA Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Genentech USA Main Business
Table 91. Genentech USA Latest Developments
Table 92. Teva Respiratory Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Respiratory Respiratory Biologics Product Portfolios and Specifications
Table 94. Teva Respiratory Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Teva Respiratory Main Business
Table 96. Teva Respiratory Latest Developments
Table 97. Novartis Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Respiratory Biologics Product Portfolios and Specifications
Table 99. Novartis Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Roche Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 103. Roche Respiratory Biologics Product Portfolios and Specifications
Table 104. Roche Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Roche Main Business
Table 106. Roche Latest Developments
Table 107. Boehringer Ingelheim Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim Respiratory Biologics Product Portfolios and Specifications
Table 109. Boehringer Ingelheim Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Boehringer Ingelheim Main Business
Table 111. Boehringer Ingelheim Latest Developments
Table 112. Regeneron Pharmaceuticals Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 113. Regeneron Pharmaceuticals Respiratory Biologics Product Portfolios and Specifications
Table 114. Regeneron Pharmaceuticals Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Regeneron Pharmaceuticals Main Business
Table 116. Regeneron Pharmaceuticals Latest Developments
Table 117. Merck Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck Respiratory Biologics Product Portfolios and Specifications
Table 119. Merck Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Merck Main Business
Table 121. Merck Latest Developments
Table 122. Johnson & Johnson Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 123. Johnson & Johnson Respiratory Biologics Product Portfolios and Specifications
Table 124. Johnson & Johnson Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Johnson & Johnson Main Business
Table 126. Johnson & Johnson Latest Developments
Table 127. Amgen Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 128. Amgen Respiratory Biologics Product Portfolios and Specifications
Table 129. Amgen Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Amgen Main Business
Table 131. Amgen Latest Developments
Table 132. Biogen Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 133. Biogen Respiratory Biologics Product Portfolios and Specifications
Table 134. Biogen Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Biogen Main Business
Table 136. Biogen Latest Developments
Table 137. Vertex Pharmaceuticals Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 138. Vertex Pharmaceuticals Respiratory Biologics Product Portfolios and Specifications
Table 139. Vertex Pharmaceuticals Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Vertex Pharmaceuticals Main Business
Table 141. Vertex Pharmaceuticals Latest Developments
Table 142. AbbVie Basic Information, Respiratory Biologics Manufacturing Base, Sales Area and Its Competitors
Table 143. AbbVie Respiratory Biologics Product Portfolios and Specifications
Table 144. AbbVie Respiratory Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. AbbVie Main Business
Table 146. AbbVie Latest Developments
LIST OF FIGURES
Figure 1. Picture of Respiratory Biologics
Figure 2. Respiratory Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Respiratory Biologics Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Respiratory Biologics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Respiratory Biologics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Respiratory Biologics Sales Market Share by Country/Region (2025)
Figure 10. Respiratory Biologics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intravenous
Figure 12. Product Picture of Subcuteneous
Figure 13. Global Respiratory Biologics Sales Market Share by Type in 2026
Figure 14. Global Respiratory Biologics Revenue Market Share by Type (2021-2026)
Figure 15. Respiratory Biologics Consumed in Asthma
Figure 16. Global Respiratory Biologics Market: Asthma (2021-2026) & (K Units)
Figure 17. Respiratory Biologics Consumed in Chronic Rhinosinasitis
Figure 18. Global Respiratory Biologics Market: Chronic Rhinosinasitis (2021-2026) & (K Units)
Figure 19. Respiratory Biologics Consumed in Hypereosinophilic Syndrome
Figure 20. Global Respiratory Biologics Market: Hypereosinophilic Syndrome (2021-2026) & (K Units)
Figure 21. Respiratory Biologics Consumed in Other
Figure 22. Global Respiratory Biologics Market: Other (2021-2026) & (K Units)
Figure 23. Global Respiratory Biologics Sale Market Share by Application (2025)
Figure 24. Global Respiratory Biologics Revenue Market Share by Application in 2026
Figure 25. Respiratory Biologics Sales by Company in 2026 (K Units)
Figure 26. Global Respiratory Biologics Sales Market Share by Company in 2026
Figure 27. Respiratory Biologics Revenue by Company in 2026 ($ millions)
Figure 28. Global Respiratory Biologics Revenue Market Share by Company in 2026
Figure 29. Global Respiratory Biologics Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Respiratory Biologics Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Respiratory Biologics Sales 2021-2026 (K Units)
Figure 32. Americas Respiratory Biologics Revenue 2021-2026 ($ millions)
Figure 33. APAC Respiratory Biologics Sales 2021-2026 (K Units)
Figure 34. APAC Respiratory Biologics Revenue 2021-2026 ($ millions)
Figure 35. Europe Respiratory Biologics Sales 2021-2026 (K Units)
Figure 36. Europe Respiratory Biologics Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Respiratory Biologics Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Respiratory Biologics Revenue 2021-2026 ($ millions)
Figure 39. Americas Respiratory Biologics Sales Market Share by Country in 2026
Figure 40. Americas Respiratory Biologics Revenue Market Share by Country (2021-2026)
Figure 41. Americas Respiratory Biologics Sales Market Share by Type (2021-2026)
Figure 42. Americas Respiratory Biologics Sales Market Share by Application (2021-2026)
Figure 43. United States Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Respiratory Biologics Sales Market Share by Region in 2026
Figure 48. APAC Respiratory Biologics Revenue Market Share by Region (2021-2026)
Figure 49. APAC Respiratory Biologics Sales Market Share by Type (2021-2026)
Figure 50. APAC Respiratory Biologics Sales Market Share by Application (2021-2026)
Figure 51. China Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 55. India Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Respiratory Biologics Sales Market Share by Country in 2026
Figure 59. Europe Respiratory Biologics Revenue Market Share by Country (2021-2026)
Figure 60. Europe Respiratory Biologics Sales Market Share by Type (2021-2026)
Figure 61. Europe Respiratory Biologics Sales Market Share by Application (2021-2026)
Figure 62. Germany Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 63. France Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Respiratory Biologics Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Respiratory Biologics Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Respiratory Biologics Sales Market Share by Application (2021-2026)
Figure 70. Egypt Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Respiratory Biologics in 2026
Figure 76. Manufacturing Process Analysis of Respiratory Biologics
Figure 77. Industry Chain Structure of Respiratory Biologics
Figure 78. Channels of Distribution
Figure 79. Global Respiratory Biologics Sales Market Forecast by Region (2027-2032)
Figure 80. Global Respiratory Biologics Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Respiratory Biologics Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Respiratory Biologics Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Respiratory Biologics Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Respiratory Biologics Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Respiratory Biologics
Figure 2. Respiratory Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Respiratory Biologics Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Respiratory Biologics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Respiratory Biologics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Respiratory Biologics Sales Market Share by Country/Region (2025)
Figure 10. Respiratory Biologics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intravenous
Figure 12. Product Picture of Subcuteneous
Figure 13. Global Respiratory Biologics Sales Market Share by Type in 2026
Figure 14. Global Respiratory Biologics Revenue Market Share by Type (2021-2026)
Figure 15. Respiratory Biologics Consumed in Asthma
Figure 16. Global Respiratory Biologics Market: Asthma (2021-2026) & (K Units)
Figure 17. Respiratory Biologics Consumed in Chronic Rhinosinasitis
Figure 18. Global Respiratory Biologics Market: Chronic Rhinosinasitis (2021-2026) & (K Units)
Figure 19. Respiratory Biologics Consumed in Hypereosinophilic Syndrome
Figure 20. Global Respiratory Biologics Market: Hypereosinophilic Syndrome (2021-2026) & (K Units)
Figure 21. Respiratory Biologics Consumed in Other
Figure 22. Global Respiratory Biologics Market: Other (2021-2026) & (K Units)
Figure 23. Global Respiratory Biologics Sale Market Share by Application (2025)
Figure 24. Global Respiratory Biologics Revenue Market Share by Application in 2026
Figure 25. Respiratory Biologics Sales by Company in 2026 (K Units)
Figure 26. Global Respiratory Biologics Sales Market Share by Company in 2026
Figure 27. Respiratory Biologics Revenue by Company in 2026 ($ millions)
Figure 28. Global Respiratory Biologics Revenue Market Share by Company in 2026
Figure 29. Global Respiratory Biologics Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Respiratory Biologics Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Respiratory Biologics Sales 2021-2026 (K Units)
Figure 32. Americas Respiratory Biologics Revenue 2021-2026 ($ millions)
Figure 33. APAC Respiratory Biologics Sales 2021-2026 (K Units)
Figure 34. APAC Respiratory Biologics Revenue 2021-2026 ($ millions)
Figure 35. Europe Respiratory Biologics Sales 2021-2026 (K Units)
Figure 36. Europe Respiratory Biologics Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Respiratory Biologics Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Respiratory Biologics Revenue 2021-2026 ($ millions)
Figure 39. Americas Respiratory Biologics Sales Market Share by Country in 2026
Figure 40. Americas Respiratory Biologics Revenue Market Share by Country (2021-2026)
Figure 41. Americas Respiratory Biologics Sales Market Share by Type (2021-2026)
Figure 42. Americas Respiratory Biologics Sales Market Share by Application (2021-2026)
Figure 43. United States Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Respiratory Biologics Sales Market Share by Region in 2026
Figure 48. APAC Respiratory Biologics Revenue Market Share by Region (2021-2026)
Figure 49. APAC Respiratory Biologics Sales Market Share by Type (2021-2026)
Figure 50. APAC Respiratory Biologics Sales Market Share by Application (2021-2026)
Figure 51. China Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 55. India Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Respiratory Biologics Sales Market Share by Country in 2026
Figure 59. Europe Respiratory Biologics Revenue Market Share by Country (2021-2026)
Figure 60. Europe Respiratory Biologics Sales Market Share by Type (2021-2026)
Figure 61. Europe Respiratory Biologics Sales Market Share by Application (2021-2026)
Figure 62. Germany Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 63. France Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Respiratory Biologics Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Respiratory Biologics Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Respiratory Biologics Sales Market Share by Application (2021-2026)
Figure 70. Egypt Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Respiratory Biologics Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Respiratory Biologics in 2026
Figure 76. Manufacturing Process Analysis of Respiratory Biologics
Figure 77. Industry Chain Structure of Respiratory Biologics
Figure 78. Channels of Distribution
Figure 79. Global Respiratory Biologics Sales Market Forecast by Region (2027-2032)
Figure 80. Global Respiratory Biologics Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Respiratory Biologics Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Respiratory Biologics Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Respiratory Biologics Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Respiratory Biologics Revenue Market Share Forecast by Application (2027-2032)
